The messenger market is presently experiencing remarkable growth, fueled by the triumphant deployment of mRNA-based immunizations against COVID-19. Research indicate a evolving landscape, with read more ongoing funding into therapeutic applications outside infectious diseases, including areas such as oncology, rare diseases, and protein replacement